Evogene Ltd. - Report Publication Announcement 2020

Press release: Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	08/09/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-099198	Time of broadcast: 12:34 12:34

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPress release: Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program

Biomica_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 04/08/2020
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected] Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: [email protected] 1

AI assistant